Aytu Bio Pharma Partners with Fabre-Kramer to Launch EXXUA
06 Jun 2025 //
ACCESSWIRE
Aytu BioPharma Announces $14.4M Upsized Public Offering of Stock
06 Jun 2025 //
ACCESSWIRE
Depression med Exxua finally cleared by FDA after 2+ decades
29 Sep 2023 //
FIERCE PHARMA
Fabre-Kramer Partners with Mission Pharmacal for Future Commercial Manufacture
03 Jan 2018 //
GLOBENEWSWIRE
FDA Advisory Panel Unmoved by Gepirone Data
02 Dec 2015 //
MEDPAGE TODAY